Physician profile
Amanda E Matthews
NPI 1982866638
$3,977.42
in general payments reported to CMS, 2019-2025
18 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,141 · 2020: $355 · 2021: $1,553 · 2022: $132 · 2023: $59.17 · 2024: $263 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743 · Gift: $36.06 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.73 |
| Gift | $36.06 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $1,332.18 | 2021-2025 | Visumax |
| Alcon Vision LLC | $899.62 | 2019-2025 | Tryptyr, Unity, Hydrus Microstent |
| Kala Pharmaceuticals, INC. | $619.97 | 2019-2020 | |
| Horizon Therapeutics Plc | $274.82 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $176.25 | 2023-2025 | Xiidra, Vyzulta, Miebo |
| Allergan, INC. | $95.07 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $93.32 | 2024 | Xdemvy |
| Glaukos Corporation | $86.03 | 2019-2024 | Idose |
| Abbvie INC. | $65.56 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $56.39 | 2019 | |
| Aerie Pharmaceuticals, INC. | $51.44 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $45.87 | 2019 | |
| New World Medical,INC. | $45.04 | 2021-2025 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Ocular Therapeutix, INC. | $35.71 | 2020 | |
| Sun Pharmaceutical Industries INC. | $32.89 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $29.18 | 2025 | Oxervate |
| Shire North American Group INC | $20.51 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $17.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.